Pharmafile Logo
Pharmafocus logo
Advanced Search

Gilead

Showing 15 posts of 244 posts found.

Gilead gets CHMP nod

November 25, 2013
Research and Development, Sales and Marketing CHMP, FDA, Gilead, chc, sovaldi

The CHMP has opened the way for Gilead Sciences’ first-in-class investigational chronic hepatitis C drug Sovaldi (sofosbuvir) to get to …

News
Gilead image

‘Game-changing’ hep C pill gets FDA panel nod

October 29, 2013
Sales and Marketing FDA, Gilead, hep C, sofosbuvir

Gilead Science’s investigational hepatitis C drug sofosbuvir is one step closer to approval in the US after an FDA advisory …

News
Stribild image

New HIV pill for UK

May 29, 2013
Sales and Marketing Gilead, HIV, stribild

Gilead Sciences has launched Stribild, a once-daily single tablet regimen to combat HIV – the virus which causes AIDS – …

News
Gilead image

Manufacturing issues block Gilead approvals

May 1, 2013
Manufacturing and Production FDA, Gilead

The FDA has blocked approval of two of Gilead Sciences’ HIV drugs because of deficiencies in their marketing applications related …

News
Gilead image

Gilead recalls Vistide on particle contamination

February 19, 2013
Manufacturing and Production Gilead, Vistide

Gilead Sciences has issued a voluntary recall of one lot of its antiviral treatment Vistide after finding particulate matter in …

News
Gilead image

Gilead licences MacroGenics technology

January 9, 2013
Research and Development, Sales and Marketing DART, Gilead, MacroGenics

Private biotech company MacroGenics has licenced its bi-specific antibody platform technology to Gilead Sciences for products aimed at four unnamed …

News
Merck image

Merck enters €110m virus alliance

October 16, 2012
Research and Development, Sales and Marketing AiCuris, Gilead, HCMV, Merck

Merck has gained access to AiCuris’ portfolio of investigational medicines targeting human cytomegalovirus (HCMV) via a global licensing agreement. It …

News

New quad HIV pill passed by FDA

September 2, 2012
Sales and Marketing FDA, Gilead, HIV, stribild

Gilead’s four-in-one anti-HIV once-daily pill Stribild has been given the green light by the FDA for adults who have not …

News

New Quad HIV pill on track for FDA approval

May 14, 2012
Research and Development, Sales and Marketing BMS, Compera, FDA, Gilead, HIV, The Quad

Gilead Sciences’ four-in-one HIV pill has been given the thumbs up by an FDA advisory group.  The US regulator is …

News

Setback for Gilead hep C candidate

February 20, 2012
Research and Development, Sales and Marketing ELECTRON, GS-7977, Gilead, Pharmasset

Gilead’s investigational hepatitis C drug has been dealt a blow after patients suffer relapses in a mid-stage trial.  In the …

News

Gilead aims for hep C lead with Pharmasset acquisition

November 22, 2011
Research and Development Gilead, HCV, Pharmasset, Victrelis, hepatitis C

Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …

News
Boehringer

Boehringer signs away HIV rights to focus on hep C

October 7, 2011
Research and Development Boehringer, Gilead, HIV, hepatitis C

Boehringer Ingelheim has signed a deal giving Gilead Sciences exclusive worldwide rights to a major part of its HIV portfolio. …

News

Triple regimen HIV pill gains approval

August 11, 2011
Gilead, HIV, J&J, JJ, Truvada

A new three-in-one pill Complera has been approved in the US as a first line treatment for HIV. Complera combines …

News

Gilead buys manufacturing plant from Genentech

August 9, 2011
Manufacturing and Production Genentech, Gilead, biologics

Roche unit Genentech has agreed to sell a clinical manufacturing plant in California to Gilead Sciences. The 70,000 sq. ft. …

News

Gilead manufacturing under investigation by US authorities

June 14, 2011
Manufacturing and Production Department of Justice, Gilead, manufacturing compliance, pharma manufacturing

Gilead Sciences is being investigated by the US authorities over the manufacturing and distribution of some of its products, and …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025